Back

Learner’s Digest International (TM)

  • Immunotherapy
  • Small Cell Lung Carcinoma

Immunotherapy in Small Cell Lung Cancer

The goal of this program is to improve utilization of immunotherapy for small cell lung cancer (SCLC). After hearing and assimilating this program, the clinician will be better able to:Follow evidence-based protocols for the management of limited-stage SCLC.Analyze clinical evidence and outcomes of immunotherapy and BiTE therapyIdentify common and severe immune-related adverse events following immunotherapy for SCLC.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1.5 credits

MOC types

ABIM — Medical KnowledgeUp to 1.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Membership pricing — $1,095 / year

This provider prices CME through membership. Individual courses may also be sold separately.

See plans on audio-digest.org

Listed by the provider

  • Enduring / On-demand
  • Credit · Up to 1.5 credits
  • MOC · Up to 1.5 points
  • Membership pricing
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Jan 8, 2029 2 years left